These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 3895668)

  • 1. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 2. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.
    Smith JL; Wilkinson AH; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3199-200. PubMed ID: 2650451
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
    Hamilton DV; Carmichael DJ; Evans DB; Calne RY
    Transplant Proc; 1982 Sep; 14(3):597-600. PubMed ID: 6758243
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 9. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 10. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid abnormalities in renal transplant recipients treated with cyclosporine.
    Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
    Boudreaux JP; McHugh L; Canafax DM; Asher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1811-3. PubMed ID: 3079040
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
    Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
    Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplant incidence of superficial fungal infection as related to immunosuppressive therapy.
    Segal R; Shmueli D; Yussim A; Sandbank M; Alteras I; Shapira Z
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2114-6. PubMed ID: 2652682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.